Showing results (71-80 of 99) with videos related to
Sort By:
Pageof 10
Genes and Immunity|October 11, 2003
Intercellular adhesion molecule-1: a protective haplotype against multiple sclerosisI Cournu-Rebeix, E Génin, G Lesca, et al.Lancet (London, England)|May 30, 2001
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised studyG Comi, M Filippi, F Barkhof, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2002
A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosisR G Ghalie, E Mauch, G Edan, et al.Journal of Neurology|April 12, 2006
Does subthalamic nucleus stimulation induce apathy in Parkinson's disease?D Drapier, S Drapier, P Sauleau, et al.Journal of Neuroimmunology|May 15, 2010
Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine responseJ Kovalchin, J Krieger, M Genova, et al.European Journal of Neurology|February 1, 2017
Survey of diagnostic and treatment practices for multiple sclerosis in EuropeO Fernández, M Delvecchio, G Edan, et al.European Journal of Neurology|January 23, 2018
Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general managementO Fernández, M Delvecchio, G Edan, et al.Neurology|August 18, 2006
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromesL Kappos, C H Polman, M S Freedman, et al.Neurology|December 29, 2005
Idiopathic acute transverse myelitis: application of the recent diagnostic criteriaJ de Seze, C Lanctin, C Lebrun, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 13, 2013
Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFITG Edan, L Kappos, X Montalbán, et al.Pageof 10